These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9867740)

  • 1. Pharmacokinetic interaction between saquinavir and cyclosporine.
    Brinkman K; Huysmans F; Burger DM
    Ann Intern Med; 1998 Dec; 129(11):914-5. PubMed ID: 9867740
    [No Abstract]   [Full Text] [Related]  

  • 2. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein.
    Kim AE; Dintaman JM; Waddell DS; Silverman JA
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1439-45. PubMed ID: 9732409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics.
    Maserati R; Villani P; Cocchi L; Regazzi MB
    AIDS; 1998 May; 12(7):815-6. PubMed ID: 9619815
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.
    Hsu A; Granneman GR; Cao G; Carothers L; el-Shourbagy T; Baroldi P; Erdman K; Brown F; Sun E; Leonard JM
    Clin Pharmacol Ther; 1998 Apr; 63(4):453-64. PubMed ID: 9585800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Frassetto L; Baluom M; Jacobsen W; Christians U; Roland ME; Stock PG; Carlson L; Benet LZ
    Transplantation; 2005 Jul; 80(1):13-7. PubMed ID: 16003227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
    Klaus BD; Grodesky MJ
    Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
    [No Abstract]   [Full Text] [Related]  

  • 8. Variability in trough plasma saquinavir concentrations in HIV patients--a case for therapeutic drug monitoring.
    Barry MG; Merry C; Lloyd J; Halifax K; Carey P; Mulcahy F; Back DJ
    Br J Clin Pharmacol; 1998 May; 45(5):501-2. PubMed ID: 9643625
    [No Abstract]   [Full Text] [Related]  

  • 9. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
    Merry C; Mulcahy F; Barry M; Gibbons S; Back D
    AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals.
    Koks CH; Crommentuyn KM; Hoetelmans RM; Burger DM; Koopmans PP; Mathôt RA; Mulder JW; Meenhorst PL; Beijnen JH
    Br J Clin Pharmacol; 2001 Jun; 51(6):631-5. PubMed ID: 11422025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Garlic supplements found to lower saquinavir levels.
    TreatmentUpdate; 2001; 12(12):17-8. PubMed ID: 11570085
    [No Abstract]   [Full Text] [Related]  

  • 12. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man.
    Kupferschmidt HH; Fattinger KE; Ha HR; Follath F; Krähenbühl S
    Br J Clin Pharmacol; 1998 Apr; 45(4):355-9. PubMed ID: 9578182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. San Franscisco area: important cyclosporin study recruiting.
    James JS
    AIDS Treat News; 1999 Mar; (No 315):8. PubMed ID: 11366562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based therapeutic drug monitoring for saquinavir].
    Muret P; Solas C;
    Therapie; 2011; 66(3):207-12. PubMed ID: 21819804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saquinavir. Clinical pharmacology and efficacy.
    Vella S; Floridia M
    Clin Pharmacokinet; 1998 Mar; 34(3):189-201. PubMed ID: 9533981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection.
    Noble S; Faulds D
    Drugs; 1996 Jul; 52(1):93-112. PubMed ID: 8799687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.
    Gutmann H; Fricker G; Drewe J; Toeroek M; Miller DS
    Mol Pharmacol; 1999 Aug; 56(2):383-9. PubMed ID: 10419558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir as Fortovase: why does it matter?
    Trapnell CB
    AIDS Clin Care; 1998 May; 10(5):37, 40. PubMed ID: 11365428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between saquinavir soft-gel and rifabutin in patients infected with HIV.
    Moyle GJ; Buss NE; Goggin T; Snell P; Higgs C; Hawkins DA
    Br J Clin Pharmacol; 2002 Aug; 54(2):178-82. PubMed ID: 12207638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
    Berginc K; Trdan T; Trontelj J; Kristl A
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):495-505. PubMed ID: 21104925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.